journal
Journals Transplant Infectious Disease ...

Transplant Infectious Disease : An Official Journal of the Transplantation Society

https://read.qxmd.com/read/38874353/donor-derived-strongyloidiasis-the-beginning-of-the-end
#1
JOURNAL ARTICLE
John I Hogan, Sapna A Mehta, Ricardo M La Hoz
No abstract text is available yet for this article.
June 14, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38874266/staphylococcus-pasteuri-isolated-in-extracorporeal-photopheresis-product-in-a-patient-affected-by-chalazion-blepharitis
#2
LETTER
Chiara Marcon, Valentina Simeon, Chiara Savignano, Giovanni Barillari
No abstract text is available yet for this article.
June 14, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38872417/which-hepatitis-e-virus-to-worry-about-in-our-transplant-patients
#3
EDITORIAL
Olivier Marion, Jacques Izopet, Nassim Kamar
No abstract text is available yet for this article.
June 14, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38853544/surveillance-for-donor-derived-infections-in-australia
#4
JOURNAL ARTICLE
Helen Ingrid Opdam, Peter Boan, Lucinda Barry, Jeremy R Chapman
BACKGROUND: Systems for quality and safety assurance in organ donation and transplantation are vital, especially those that seek to minimize donor disease transmission. Australia has developed a national vigilance and surveillance system to identify, review, and analyze actual and potential donor-derived infections and other disease transmissions. METHODS: The system involves notification of incidents to the Australian Organ and Tissue Authority for review by a Vigilance and Surveillance Expert Advisory Committee (VSEAC)...
June 10, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38852068/the-american-association-of-tissue-banks-tissue-donor-screening-for-mycobacterium-tuberculosis-recommended-criteria-and-literature-review
#5
REVIEW
Melissa A Greenwald, Noelle Edwards, D Ted Eastlund, Inga Gurevich, Andrea Pervine-Zaman Ho, Ghada Khalife, Janet Lin-Torre, Hannis W Thompson, Ross M Wilkins, Sally F Alrabaa
After two multistate outbreaks of allograft tissue-transmitted tuberculosis (TB) due to viable bone, evidence-based donor screening criteria were developed to decrease the risk of transmission to recipients. Exclusionary criteria, commentary, and references supporting the criteria are provided, based on literature search and expert opinion. Both exposure and reactivation risk factors were considered, either for absolute exclusion or for exclusion in combination with multiple risk factors. A criteria subset was devised for tissues containing viable cells...
June 9, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38852067/donor-derived-infections-the-swiss-perspective
#6
REVIEW
Nicolas J Mueller, Oriol Manuel, Cédric Hirzel
While Switzerland has not yet established a systematic approach, the small size of the country and the intensive collaboration between the transplant infectious disease teams facilitate a rapid communication once a donor-derived infection is suspected. Critical information regarding donor infections is shared rapidly, and appropriate measures are discussed. The long-term observational Swiss Transplant Cohort Study, which includes >92% of all solid organ recipients collects all relevant infectious disease episodes and facilitates detection of patterns of potential donor-derived infection...
June 9, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38852064/hospitalizations-for-opportunistic-infections-following-transplantation-and-associated-risk-factors-a-national-cohort-study-of-medicare-beneficiaries
#7
JOURNAL ARTICLE
Alyssa K Mezochow, Douglas E Schaubel, Eliot G Peyster, James D Lewis, David S Goldberg, Therese Bittermann
BACKGROUND: Opportunistic infections (OIs) are a significant cause of morbidity and mortality after organ transplantation, though data in the liver transplant (LT) population are limited. METHODS: We performed a retrospective cohort study of LT recipients between January 1, 2007 and Deceber 31, 2016 using Medicare claims data linked to the Organ Procurement and Transplantation Network database. Multivariable Cox regression models evaluated factors independently associated with hospitalizations for early (≤1 year post transplant) and late (>1 year) OIs, with a particular focus on immunosuppression...
June 9, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38830813/donor-derived-mold-infections-in-lung-transplant-recipients-the-importance-of-active-surveillance
#8
JOURNAL ARTICLE
Alessandra Mularoni, Andrea Cona, Giulia Coniglione, Floriana Barbera, Giuseppina Di Martino, Giovanni Mulè, Maria Campanella, Giuseppina Di Mento, Giuseppe Nunnari, Paolo Antonio Grossi, Maurizio Sanguinetti, Malgorzata Mikulska, Elena De Carolis, Alessandro Bertani
Unexpected donor-derived fungal infections represent a rare but potentially fatal complication in lung transplant (Tx) recipients. Timely communication of the results of donor cultures and prompt treatment of recipients are crucial to mitigate the consequences of donor-derived transmissions. In this prospective cohort study, all consecutive patients who underwent lung transplantation from 2015 to 2022 were included. In December 2015, a Local Active Surveillance System has been implemented to provide biovigilance of donor culture results and optimize recipients' management...
June 3, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38830809/adenovirus-and-cytomegalovirus-specific-adoptive-t-cell-therapy-in-the-context-of-hematologic-cell-transplan-or-hiv-infection-a-single-center-experience
#9
JOURNAL ARTICLE
Benedikt Obermaier, Christiane Braun, Luca Hensen, Osama Ahmad, Christoph Faul, Peter Lang, Wolfgang Bethge, Claudia Lengerke, Wichard Vogel
BACKGROUND: Reactivation of viral infections, in particular cytomegalovirus (CMV) and adenovirus (ADV), cause morbidity and non-relapse-mortality in states of immune deficiency, especially after allogeneic hematopoietic cell transplantation (allo-HCT). Against the background of few available pharmacologic antiviral agents, limited by toxicities and resistance, adoptive transfer of virus-specific T-cells (VST) is a promising therapeutic approach. METHODS: We conducted a single-center retrospective analysis of adult patients treated with ADV- or CMV-specific T-cells in 2012-2022...
June 3, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38830781/anal-dysplasia-and-anal-cancer-in-liver-transplant-recipients-an-urgent-call-for-action-for-anal-cancer-screening-and-further-research
#10
EDITORIAL
Helen Cristina Stankiewicz Karita, Cristina Elena Brickman, Peter Chin-Hong
No abstract text is available yet for this article.
June 3, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38824435/comparison-of-prophylaxis-and-preemptive-strategy-as-cytomegalovirus-prevention-in-liver-transplant-recipients
#11
JOURNAL ARTICLE
Christophe Camus, Mélanie Poinot, Charlotte Pronier, Michel Rayar, Anne Le Neillon, Marianne Latournerie, Gisèle Lagathu, Matthieu Revest
OBJECTIVES: Prophylaxis (P) or pre-emptive strategy (PS) in high-risk liver transplant recipients (LTRs) are either recommended. We compared the results of each strategy. METHODS: Two groups of LTR transplanted during two consecutive periods were compared. Only cytomegalovirus (CMV)-mismatched LTR (Donor +/ Recipient -) were included. The primary endpoints were: the onset of polymerase chain reaction-based DNAemia and the proportion of patients with CMV disease...
June 2, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38809102/antiviral-therapies-for-the-management-of-persistent-coronavirus-disease-2019-in-immunocompromised-hosts-a-narrative-review
#12
REVIEW
Paul M Kinsella, Michael A Moso, Catherine Orla Morrissey, Claire Dendle, Stephen Guy, Katherine Bond, Joseph Sasadeusz, Monica A Slavin
Antiviral agents with activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played a critical role in disease management; however, little is known regarding the efficacy of these medications in the treatment of SARS-CoV-2 infection in immunocompromised patients, particularly in the management of persistent SARS-CoV-2 positivity. This narrative review discusses the management of persistent coronavirus disease 2019 in immunocompromised hosts, with a focus on antiviral therapies. We identified 84 cases from the literature describing a variety of approaches, including prolonged antiviral therapy (n = 11), combination antivirals (n = 13), and mixed therapy with antiviral and antibody treatments (n = 60)...
May 29, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38809085/organ-donation-and-hiv-awareness-and-willingness-to-be-a-living-donor-among-people-with-hiv-in-uganda
#13
JOURNAL ARTICLE
Felix Bongomin, Ritah Nantale, Winnie Kibone, Byron Awekonimungu, Nixson Oyoo, James Okello, Conrad Muzoora, Davidson H Hamer
BACKGROUND: HIV+-to-HIV+ organ transplantation has demonstrated promise and is now authorized for research purposes in certain countries. However, organ transplantation is dependent on the availability of organ donors. We assessed the awareness and willingness to donate organs among people with HIV (PWH) in Uganda. METHODS: We conducted a multicenter cross-sectional study between October 2023 and January 2024 in four large HIV clinics in Northern Uganda. The study population consisted of PWH...
May 29, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38775175/chronic-hepatitis-e-masquerading-as-allograft-rejection-in-a-liver-transplant-recipient
#14
JOURNAL ARTICLE
Samuel Thorburn, Avik Majumdar, Olivia Smibert
No abstract text is available yet for this article.
May 22, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38775174/low-seroprevalence-of-anti-human-t-cell-leukemia-virus-i-ii-antibodies-among-brain-dead-donors-in-tuscany-an-8-year-observational-study
#15
LETTER
Chiara Lazzeri, Paolo Antonio Grossi, Arianna Precisi O Procissi, Gian Maria Rossolini, Maria Grazia Cusi, Paolo Lo Pane, Sara Bagatti, Lara Entani Santini, Adriano Peris
No abstract text is available yet for this article.
May 22, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38761060/utilization-of-hepatitis-b-viremic-donors-nat-leads-to-improved-kidney-transplant-access-for-older-adult-recipients-with-little-to-no-wait-time
#16
JOURNAL ARTICLE
Reynold I Lopez-Soler, Cara Joyce, Laura Cotiguala, Oswaldo Aguirre, Manpreet Samra, Chrsitine Trotter, Geraldine Zingraf, Jeffrey Sorensen, Rupinder Sodhi, Anne Thorndyke
BACKGROUND: Though the use of Hepatitis B viremic (HBV) donor kidneys may be a safe alternative to improve access to transplantation, there has not been wide acceptance of this practice. In this study, we determined the safety and effectiveness of HBV NAT (+) donor kidneys in a protocolized manner in an older adult population. METHODS: Over a 3-year period, 16 decreased donor kidney transplants were performed with HBV NAT+ kidneys. Recipients of HBV NAT+ kidneys were treated with entecavir started pre-operatively and continued for 52 weeks...
May 18, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38761053/infective-endocarditis-is-rare-in-patients-with-hematologic-malignancy-and-neutropenia
#17
JOURNAL ARTICLE
Michael J Scolarici, Leigh R Berman, Natalie Callander, Jeannina Smith, Christopher Saddler
BACKGROUND: Infective endocarditis (IE) is a serious complication of bloodstream infections (BSIs) that occurs at variable rates depending on the pathogen and clinical setting. There is a paucity of data describing the risk of IE in patients with hematologic malignancy who develop bacteremia while neutropenic. METHODS: Adult patients on the hematology ward from January 2018 to December 2020 with hematologic malignancy and bacteremia were evaluated retrospectively for endocarditis by applying the 2023 Duke-ISCVID criteria...
May 18, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38742608/letermovir-for-cytomegalovirus-prophylaxis-in-lung-transplant-recipients-a-promising-shift-toward-reduced-myelotoxicity
#18
EDITORIAL
Muath Alsharif, Kelly M Pennington
No abstract text is available yet for this article.
May 14, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38742601/evaluating-the-efficacy-and-safety-of-letermovir-compared-to-valganciclovir-for-the-prevention-of-human-cytomegalovirus-disease-in-adult-lung-transplant-recipients
#19
JOURNAL ARTICLE
Sydni Martinez, Devika Sindu, Michael D Nailor, Lauren Cherrier, Sofya Tokman, Rajat Walia, Kellie J Goodlet
BACKGROUND: Lung transplant recipients are at high risk for severe cytomegalovirus (CMV) disease. Off-label use of letermovir (LET) may avert myelotoxicity associated with valganciclovir (VGCV), but data in lung transplantation are limited. This study aims to evaluate the outcomes of LET prophylaxis among lung transplant recipients. METHODS: This retrospective, matched cohort study included lung transplant recipients who received LET for primary CMV prophylaxis following VGCV intolerance...
May 14, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/38728099/cytomegalovirus-surveillance-after-antiviral-prophylaxis-in-cmv-mismatched-transplant-patients-does-recurrent-cytomegalovirus-dnaemia-impact-patient-survival
#20
JOURNAL ARTICLE
Oscar A Fernández-García, Cristina Hernandez, Mark Robbins, Dima Kabbani, Karen Doucette, Carlos Cervera
BACKGROUND: Cytomegalovirus (CMV) mismatched, donor IgG-positive/recipient IgG-negative, solid organ transplant recipients (SOTRs) are at high risk of CMV invasive disease. Post-prophylaxis disease is an issue in this population. Some programs employ surveillance after prophylaxis (SAP) to limit the incidence of post-prophylaxis disease. METHODS: This was a single-center retrospective cohort study that included all CMV mismatched SOTRs from 2003 to 2017. Patients underwent SAP with weekly CMV plasma viral load for 12 weeks...
May 10, 2024: Transplant Infectious Disease: An Official Journal of the Transplantation Society
journal
journal
34608
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.